Conclusions The available evidence suggests that GOLD 2011 strategy presented a low reliability, and its theorized multidimensionality was not confirm by EFA. Comorbidities appears as a separate and independent domain.

Source: Pulmonary Pharmacology and Therapeutics
Read Full Article